Wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Chapter 10 : Stability testing management

Total questions: 15

Worksheet time: 8mins

Name
Class
Date
1.

Which objective best describes why stability testing determines shelf life for a medicine?

a)

To meet hospital inventory forecasting

b)

To compare brands in the marketplace

c)

To reduce manufacturing costs annually

d)

To define safe and effective usage period

2.

Under ICH Q1A, what is the standard accelerated storage condition for most products?

a)

30°C ± 2°C and 65% RH ± 5%

b)

5°C ± 2°C and 35% RH ± 5%

c)

25°C ± 2°C and 60% RH ± 5%

d)

40°C ± 2°C and 75% RH ± 5%

3.

Which factor primarily explains faster chemical degradation at higher temperatures?

a)

Arrhenius principle with increased rate constants

b)

Galenic principle of excipient balance

c)

Henry’s law of gas solubility in liquids

d)

Le Chatelier principle shifting equilibria

4.

For long‑term stability studies in Climatic Zone IVb, which standard condition is typically applied?

a)

30°C ± 2°C and 65% RH ± 5%

b)

20°C ± 2°C and 50% RH ± 5%

c)

40°C ± 2°C and 75% RH ± 5%

d)

25°C ± 2°C and 60% RH ± 5%

5.

Which chemical factor is most likely to accelerate oxidation of drugs like adrenaline?

a)

Exposure to oxygen in headspace

b)

Increase in particle size distribution

c)

Polymorphism of the active crystal

d)

Phase separation within emulsion

6.

How does particle size influence physical stability of solid dosage forms?

a)

Uniform particles eliminate hydrolysis and oxidation

b)

Larger particles reduce flow and improve stability

c)

Irregular particles prevent photodegradation entirely

d)

Smaller particles increase surface area, faster degradation

7.

Which requirement ensures analytical methods can track product degradation reliably?

a)

Reliance on vendor certificates

b)

Annual instrument calibration only

c)

Use of non‑specific color tests

d)

Validated stability‑indicating capability

8.

A formulation shows incompatibility between API and excipient. What is the most appropriate stability risk?

a)

Improved polymorphic consistency

b)

Accelerated degradation from interactions

c)

Guaranteed protection from photolysis

d)

Elimination of microbial contamination

9.

Which batch selection approach best supports a robust stability program for a new tablet product?

a)

Select four batches with varying packaging types

b)

Evaluate two batches from different formulations

c)

Test one pilot batch under mixed processes

d)

Use minimum three batches with same process

10.

When choosing storage conditions for stability studies, which factor most directly determines temperature and humidity settings?

a)

Marketing authorization submission date

b)

Supplier lead time variability

c)

Climatic zone classification of markets

d)

Packaging artwork color scheme

11.

Which combination reflects typical long‑term and accelerated sampling schedules for stability studies?

a)

Long‑term 0–6 months; accelerated 0–24 months

b)

Long‑term 3–9 months; accelerated 12–24 months

c)

Long‑term 0–12 months; accelerated 0–18 months

d)

Long‑term 0–24 months; accelerated 0–6 months

12.

A method is considered stability‑indicating when it can do which action?

a)

Estimate packaging headspace volume

b)

Measure excipient particle morphology

c)

Separate API from degradation products

d)

Predict patient adherence behavior

13.

Which set of tests is most appropriate for routine stability evaluation of solid oral dosage forms?

a)

Genomic sequencing, proteomics, metabolomics

b)

Thermal imaging, RFID tracking, barcode checks

c)

Assay, degradation products, dissolution, pH

d)

Colorimetry, XRPD, magnetic susceptibility

14.

What is the primary purpose of ongoing (commitment) stability studies after approval?

a)

Confirm consistency of commercial batches

b)

Reduce regulatory submission formatting

c)

Determine new clinical trial endpoints

d)

Optimize sales forecasting algorithms

15.

Which outcome best captures the importance of pharmaceutical stability testing for public health?

a)

Ensures patient safety and therapeutic effectiveness

b)

Improves brand logo recognition in clinics

c)

Accelerates social media marketing engagement

d)

Eliminates the need for GMP documentation entirely